Strattera and Underweight - a phase IV clinical study of FDA data
Summary:
Underweight is reported as a side effect among people who take Strattera (atomoxetine hydrochloride), especially for people who are male, 2-9 old, have been taking the drug for 2 - 5 years also take Ritalin,.
The phase IV clinical study analyzes which people have Underweight when taking Strattera. It is created by eHealthMe based on reports of 27,428 people who have side effects when taking Strattera from the FDA, and is updated regularly.
What is Strattera?
Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,323 Strattera users. Check the latest studies of Strattera.
What is Underweight?
Underweight is found to be associated with 257 drugs and 383 conditions by eHealthMe. Check the latest studies of Underweight.
27,428 people reported to have side effects when taking Strattera.
Among them, 12 people (0.04%) have Underweight.

Among these 12 people:
How long have people been on Strattera when they have Underweight? *
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 100 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Underweight when taking Strattera? *
- female: 18.18 %
- male: 81.82 %
What is the age of people who have Underweight when taking Strattera? *
- 0-1: 0.0 %
- 2-9: 77.78 %
- 10-19: 22.22 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
What are other drugs people take besides Strattera? *
- Ritalin: 3 people, 25.00%
- Ritalin La: 1 person, 8.33%
- Focalin Xr: 1 person, 8.33%
What are other side effects people have besides Underweight? *
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 33.33%
- Withdrawal Syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance): 2 people, 16.67%
- Skin Wrinkling (wrinkle on skin): 2 people, 16.67%
- Abnormal Behavior: 2 people, 16.67%
- Developmental Delay: 2 people, 16.67%
- Drug Dependence: 2 people, 16.67%
- Headache (pain in head): 2 people, 16.67%
- Growth Retardation (delayed growth): 2 people, 16.67%
- Tic (a sudden, repetitive, nonrhythmic motor movement or vocalization involving discrete muscle groups): 2 people, 16.67%
- Sneezing: 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Strattera and have Underweight?
- Check whether Underweight is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Strattera:
- Strattera (29,323 reports)
Underweight treatments and more:
- Underweight (2,478 reports)
How severe was Underweight and when was it recovered:
Expand to all the drugs that have ingredients of atomoxetine hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Strattera:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Underweight:
- Underweight (257 drugs)
Browse all the conditions that are associated with Underweight:
- Underweight (383 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on atomoxetine hydrochloride (the active ingredients of Strattera) and Strattera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Duoneb and Naproxen - 8 seconds ago
- Could Risperidone cause Mobility Decreased? - 59 seconds ago
- Could Prevacid cause Buttock Pain? - a minute ago
- Could Cortef cause Stroke? - a minute ago
- Type 1 Diabetes and Diabetic Retinopathy - a minute ago
- Drug interactions of Levoxyl and Micro-K - 2 minutes ago
- Could Mycamine cause Hepatitis? - 2 minutes ago
- Could Amicar cause Drug Ineffective? - 2 minutes ago
- Could Acetaminophen cause Mean Cell Volume Decreased? - 2 minutes ago
- Could Cladribine cause Lymphocyte Count Decreased? - 3 minutes ago